Skip to Main Content

Author Details

Alex Kentsis
Memorial Sloan-Kettering Cancer Center
1998
106
41
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38048594A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML.Blood2024
38048594A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML.Blood2024
36451260The tumor microenvironment and immune targeting therapy in pediatric renal tumors.Pediatr Blood Cancer2023
38037453Epigenetic Cooperativity as a Therapeutic Vulnerability in Cancer.Cancer Res2023
37418425Integrative Proteogenomics Using ProteomeGenerator2.J Proteome Res2023
37085479RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells.Nat Commun2023
36711693Integrative proteogenomics using ProteomeGenerator2.bioRxiv2023
36798379Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy.bioRxiv2023
36451260The tumor microenvironment and immune targeting therapy in pediatric renal tumors.Pediatr Blood Cancer2023
37535603SETD1A function in leukemia is mediated through interaction with mitotic regulators BuGZ/BUB3.EMBO Rep2023
37163102A transposase-derived gene required for human brain development.bioRxiv2023
37535603SETD1A function in leukemia is mediated through interaction with mitotic regulators BuGZ/BUB3.EMBO Rep2023
38037453Epigenetic Cooperativity as a Therapeutic Vulnerability in Cancer.Cancer Res2023
37085479RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells.Nat Commun2023
37418425Integrative Proteogenomics Using ProteomeGenerator2.J Proteome Res2023
37163102A transposase-derived gene required for human brain development.bioRxiv2023
36711693Integrative proteogenomics using ProteomeGenerator2.bioRxiv2023
36798379Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy.bioRxiv2023
34837181Automated Multidimensional Nanoscale Chromatography for Ultrasensitive Targeted Mass Spectrometry.Methods Mol Biol2022
36154077Quantitative Cell Proteomic Atlas: Pathway-Scale Targeted Mass Spectrometry for High-Resolution Functional Profiling of Cell Signaling.J Proteome Res2022
35020834Myb drives B-cell neoplasms and myeloid malignancies in vivo.Blood Adv2022
34837181Automated Multidimensional Nanoscale Chromatography for Ultrasensitive Targeted Mass Spectrometry.Methods Mol Biol2022
34582559The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML.Blood2022
36154077Quantitative Cell Proteomic Atlas: Pathway-Scale Targeted Mass Spectrometry for High-Resolution Functional Profiling of Cell Signaling.J Proteome Res2022
35020834Myb drives B-cell neoplasms and myeloid malignancies in vivo.Blood Adv2022
34582559The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML.Blood2022
33450253The C-terminal Domain of piggyBac Transposase Is Not Required for DNA Transposition.J Mol Biol2021
34127257Corrigendum to "The C-terminal Domain of piggyBac Transposase is not Required for DNA Transposition" [J. Mol. Biol. 433 (2021) 166805].J Mol Biol2021
33749263Discovery of Protein Modifications Using Differential Tandem Mass Spectrometry Proteomics.J Proteome Res2021
33539889The piggyBac-derived protein 5 (PGBD5) transposes both the closely and the distantly related piggyBac-like elements Tcr-pble and Ifp2.J Mol Biol2021
33527899Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.Elife2021
33941673Integrative analysis reveals unique structural and functional features of the Smc5/6 complex.Proc Natl Acad Sci U S A2021
33450253The C-terminal Domain of piggyBac Transposase Is Not Required for DNA Transposition.J Mol Biol2021
33980539Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.Cancer Discov2021
34308366Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.Nat Cancer2021
33539889The piggyBac-derived protein 5 (PGBD5) transposes both the closely and the distantly related piggyBac-like elements Tcr-pble and Ifp2.J Mol Biol2021
33749263Discovery of Protein Modifications Using Differential Tandem Mass Spectrometry Proteomics.J Proteome Res2021
33527899Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.Elife2021
33941673Integrative analysis reveals unique structural and functional features of the Smc5/6 complex.Proc Natl Acad Sci U S A2021
34127257Corrigendum to "The C-terminal Domain of piggyBac Transposase is not Required for DNA Transposition" [J. Mol. Biol. 433 (2021) 166805].J Mol Biol2021
33980539Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.Cancer Discov2021
34308366Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.Nat Cancer2021
3232005011p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.Cancer2020
3232005011p15.5 epimutations in children with Wilms tumor and hepatoblastoma detected in peripheral blood.Cancer2020
32411637Developmental Mutators and Early Onset Cancer.Front Pediatr2020
32391946Why do young people get cancer?Pediatr Blood Cancer2020
32918070Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors.Nat Genet2020
32918070Author Correction: PGBD5 promotes site-specific oncogenic mutations in human tumors.Nat Genet2020
32391946Why do young people get cancer?Pediatr Blood Cancer2020
32411637Developmental Mutators and Early Onset Cancer.Front Pediatr2020
  • 1 - 50 of 212

Recommended Authors

Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2015
Number of shared co-authors 0
British Columbia Cancer Research Institute
Career Start Year 2013
Number of shared co-authors 0
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 5
Washington University School of Medicine
Career Start Year 2012
Number of shared co-authors 0
The Francis Crick Institute
Career Start Year 2008
Number of shared co-authors 0
University of Laval
Career Start Year 2007
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 3
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 11
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 1
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 15
University of California San Francisco
Career Start Year 2002
Number of shared co-authors 1
Spanish National Cancer Research Centre-CNIO
Career Start Year 2002
Number of shared co-authors 1
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 0
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
College Street, University of Toronto
Career Start Year 2000
Number of shared co-authors 0
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year 2000
Number of shared co-authors 4
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Erasmus Medical Center
Career Start Year 2000
Number of shared co-authors 0
Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke (CRCHUS)
Career Start Year 1999
Number of shared co-authors 1
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 2
Institut Curie, PSL Research University
Career Start Year 1996
Number of shared co-authors 1
Lunenfeld-Tanenbaum Research Institute
Career Start Year 1994
Number of shared co-authors 2
University of Montreal
Career Start Year 1992
Number of shared co-authors 3
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 11
Broad Institute of Harvard and MIT
Career Start Year 1990
Number of shared co-authors 6
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 15
Baylor College of Medicine
Career Start Year 1984
Number of shared co-authors 15
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year 1984
Number of shared co-authors 8

Collaborators

Boston Children's Hospital, USA Harvard Medical School, Harvard Medical School
Co-authored papers 12
Co-authored papers 12
Co-authored papers 9
Dana-Farber Cancer Institute
Co-authored papers 9
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Co-authored papers 8
Co-authored papers 7
Boston Children's Hospital
Co-authored papers 7
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
Feil Family Brain and Mind Research Institute.
Co-authored papers 5
Co-authored papers 5
University of Massachusetts Medical School
Co-authored papers 4
Institucio Catalana de Recerca i Estudis Avancats (ICREA)
Co-authored papers 4
Institute of Molecular and Cell Biology
Co-authored papers 4
Co-authored papers 4
Ann & Robert H. Lurie Children's Hospital of Chicago
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Dana-Farber Cancer Institute
Co-authored papers 4
Variant Bio Inc.
Co-authored papers 4
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Co-authored papers 3
Mission Therapeutics Ltd. Glenn Berge Building
Co-authored papers 3